Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aimei Health Technology (AFJK) Change in Accured Expenses (2024 - 2025)

Aimei Health Technology (AFJK) has 2 years of Change in Accured Expenses data on record, last reported at -$16488.0 in Q3 2025.

  • On a quarterly basis, Change in Accured Expenses fell 119.96% to -$16488.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $150583.0, a N/A change, with the full-year FY2024 number at $274673.0, up 1005.72% from a year prior.
  • Change in Accured Expenses reached -$16488.0 in Q3 2025 per AFJK's latest filing, up from -$148323.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for AFJK hit a ceiling of $157906.0 in Q1 2025 and a floor of -$148323.0 in Q2 2025.